Trials / Sponsors / VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) Triple-negative Breast Cancer, Non-squamous Non-small-cell Lung Cancer, NSCLC | Phase 2 | 2020-10-07 |
| Completed | A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001 Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma | Phase 1 | 2019-03-14 |